THE US Food and Drug
Administration has approved Tris
Pharmaceuticals generic of
hydrocodone polistirex and
chlorpheniramine polistirex).The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 08 Oct 10 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Oct 10
PHARMACIES are likely to be offered a “little bit of leniency” as they go through the COVID-19 crisis, with banks viewing the sector positively, Medici Valuations Director, Christian Sirianni, believes.